vs
GLACIER BANCORP, INC.（GBCI）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
GLACIER BANCORP, INC.的季度营收约是REPLIGEN CORP的1.5倍（$306.8M vs $197.9M），GLACIER BANCORP, INC.净利率更高（26.8% vs 6.7%，领先20.1%），过去两年GLACIER BANCORP, INC.的营收复合增速更高（24.3% vs 14.4%）
Glacier Bancorp, Inc.是美国区域性多银行控股公司，总部位于蒙大拿州卡利斯佩尔，前身为1990年在特拉华州注册成立的企业。集团面向个人及商业客户提供各类银行服务，在全美8个州共设有221个营业网点。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
GBCI vs RGEN — 直观对比
营收规模更大
GBCI
是对方的1.5倍
$197.9M
净利率更高
GBCI
高出20.1%
6.7%
两年增速更快
GBCI
近两年复合增速
14.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $306.8M | $197.9M |
| 净利润 | $82.1M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 26.8% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $0.63 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GBCIRGEN
| Q1 26 | $306.8M | — | ||
| Q4 25 | $306.5M | $197.9M | ||
| Q3 25 | $260.7M | $188.8M | ||
| Q2 25 | $240.6M | $182.4M | ||
| Q1 25 | $222.6M | $169.2M | ||
| Q4 24 | $223.0M | $174.1M | ||
| Q3 24 | $214.9M | $154.9M | ||
| Q2 24 | $198.7M | $154.1M |
净利润GBCIRGEN
| Q1 26 | $82.1M | — | ||
| Q4 25 | $63.8M | $13.3M | ||
| Q3 25 | $67.9M | $14.9M | ||
| Q2 25 | $52.8M | $14.9M | ||
| Q1 25 | $54.6M | $5.8M | ||
| Q4 24 | $61.8M | $-30.3M | ||
| Q3 24 | $51.1M | $-654.0K | ||
| Q2 24 | $44.7M | $3.3M |
毛利率GBCIRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率GBCIRGEN
| Q1 26 | — | — | ||
| Q4 25 | 24.9% | 9.0% | ||
| Q3 25 | 32.7% | 8.9% | ||
| Q2 25 | 27.1% | 7.6% | ||
| Q1 25 | 28.5% | 3.9% | ||
| Q4 24 | 33.0% | -17.7% | ||
| Q3 24 | 28.9% | -5.1% | ||
| Q2 24 | 27.3% | 1.0% |
净利率GBCIRGEN
| Q1 26 | 26.8% | — | ||
| Q4 25 | 20.8% | 6.7% | ||
| Q3 25 | 26.0% | 7.9% | ||
| Q2 25 | 21.9% | 8.2% | ||
| Q1 25 | 24.5% | 3.4% | ||
| Q4 24 | 27.7% | -17.4% | ||
| Q3 24 | 23.8% | -0.4% | ||
| Q2 24 | 22.5% | 2.2% |
每股收益（稀释后）GBCIRGEN
| Q1 26 | $0.63 | — | ||
| Q4 25 | $0.49 | $0.24 | ||
| Q3 25 | $0.57 | $0.26 | ||
| Q2 25 | $0.45 | $0.26 | ||
| Q1 25 | $0.48 | $0.10 | ||
| Q4 24 | $0.55 | $-0.55 | ||
| Q3 24 | $0.45 | $-0.01 | ||
| Q2 24 | $0.39 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $4.2B | $2.1B |
| 总资产 | $31.7B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资GBCIRGEN
| Q1 26 | $1.4B | — | ||
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M |
总债务GBCIRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益GBCIRGEN
| Q1 26 | $4.2B | — | ||
| Q4 25 | $4.2B | $2.1B | ||
| Q3 25 | $3.6B | $2.1B | ||
| Q2 25 | $3.5B | $2.1B | ||
| Q1 25 | $3.3B | $2.0B | ||
| Q4 24 | $3.2B | $2.0B | ||
| Q3 24 | $3.2B | $2.0B | ||
| Q2 24 | $3.1B | $2.0B |
总资产GBCIRGEN
| Q1 26 | $31.7B | — | ||
| Q4 25 | $32.0B | $2.9B | ||
| Q3 25 | $29.0B | $2.9B | ||
| Q2 25 | $29.0B | $2.9B | ||
| Q1 25 | $27.9B | $2.9B | ||
| Q4 24 | $27.9B | $2.8B | ||
| Q3 24 | $28.2B | $2.8B | ||
| Q2 24 | $27.8B | $2.9B |
负债/权益比GBCIRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流GBCIRGEN
| Q1 26 | — | — | ||
| Q4 25 | $374.4M | $25.7M | ||
| Q3 25 | $112.4M | $48.1M | ||
| Q2 25 | $86.0M | $28.6M | ||
| Q1 25 | $52.4M | $15.0M | ||
| Q4 24 | $258.0M | $39.2M | ||
| Q3 24 | $150.1M | $49.3M | ||
| Q2 24 | $62.7M | $42.2M |
自由现金流GBCIRGEN
| Q1 26 | — | — | ||
| Q4 25 | $347.6M | $17.6M | ||
| Q3 25 | $104.8M | $43.4M | ||
| Q2 25 | $79.5M | $21.5M | ||
| Q1 25 | $46.8M | $11.4M | ||
| Q4 24 | $209.8M | $33.6M | ||
| Q3 24 | $137.7M | $42.3M | ||
| Q2 24 | $44.1M | $37.4M |
自由现金流率GBCIRGEN
| Q1 26 | — | — | ||
| Q4 25 | 113.4% | 8.9% | ||
| Q3 25 | 40.2% | 23.0% | ||
| Q2 25 | 33.1% | 11.8% | ||
| Q1 25 | 21.0% | 6.8% | ||
| Q4 24 | 94.1% | 19.3% | ||
| Q3 24 | 64.1% | 27.3% | ||
| Q2 24 | 22.2% | 24.3% |
资本支出强度GBCIRGEN
| Q1 26 | — | — | ||
| Q4 25 | 8.8% | 4.1% | ||
| Q3 25 | 2.9% | 2.5% | ||
| Q2 25 | 2.7% | 3.9% | ||
| Q1 25 | 2.5% | 2.1% | ||
| Q4 24 | 21.6% | 3.2% | ||
| Q3 24 | 5.8% | 4.5% | ||
| Q2 24 | 9.3% | 3.1% |
现金转化率GBCIRGEN
| Q1 26 | — | — | ||
| Q4 25 | 5.87× | 1.93× | ||
| Q3 25 | 1.66× | 3.23× | ||
| Q2 25 | 1.63× | 1.92× | ||
| Q1 25 | 0.96× | 2.57× | ||
| Q4 24 | 4.18× | — | ||
| Q3 24 | 2.94× | — | ||
| Q2 24 | 1.40× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GBCI
| Net Interest Income | $268.7M | 88% |
| Noninterest Income | $38.1M | 12% |
RGEN
暂无分部数据
